Monika Killer presents the 12-month results of the Artisse INSPIRE registry, a multicenter prospective study including over 300 patients. The device shows high conformability to aneurysm shape and excellent safety. Most cases required no adjunctive devices or prolonged antiplatelet therapy, reinforcing Artisse as a simple, reliable, and effective solution for both ruptured and unruptured aneurysms up to 7 mm.
This video is an extract from the LINNC online webinar titled “ How do next-generation intrasaccular devices optimise aneurysm treatment and improve patient outcomes? ”
This program is supported by